文献速递其他结缔组织病

识别硬化性肌炎谱:HEp-2 ANA模式可识别抗SMN自身抗体相关的新临床亚群

Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
PubMed 文献 · RMD Open · 2020-01-01

该回顾性研究纳入20例专家诊断的血清阴性硬化性肌炎患者,分析其SSc特征及HEp-2 IIF核型。斑点型者携带多种罕见SSc特异性抗体;核点型者与抗SMN复合物抗体相关,以钙质沉着为特征但ILD和肾危象少见。

要点

  • 血清阴性硬化性肌炎早期常无SSc皮肤受累,肌炎可为首发非雷诺表现。
  • HEp-2 IIF核点型提示抗SMN抗体,与钙质沉着相关,ILD和肾危象少见。
  • ANA阴性硬化性肌炎需警惕ILD和肾危象。

核心结论

  • 血清阴性硬化性肌炎可依据HEp-2 IIF核型分为三种新的临床血清学亚群。
  • 核点型伴抗SMN抗体者以钙质沉着为特征,ILD和肾危象不常见。

研究设计与样本

  • 回顾性分析20例专家诊断的血清阴性硬化性肌炎患者。
  • 采用HEp-2 IIF核型(按国际共识)和蛋白A辅助免疫沉淀分析特异性。

主要发现

  • 肌炎诊断时45%患者为SSc sine scleroderma,55%以肌炎为首发非雷诺表现。
  • 11例受检者中10例(91%)存在下食管运动障碍。
  • 随访时80%患者符合ACR/EULAR SSc分类标准。
  • ANA阴性亚群与ILD和肾危象相关;斑点型亚群携带多种罕见SSc特异性抗体;核点型亚群与抗SMN复合物抗体相关。

关键数值与推荐

  • HEp-2 IIF核型阳性者滴度均≥1/320。
  • 下食管运动障碍在受检患者中占10/11(91%)。
  • 随访时80%符合ACR/EULAR SSc分类标准。

临床怎么用

  • 对血清阴性硬化性肌炎应进行HEp-2 IIF核型分析以识别新亚群。
  • ANA阴性患者需筛查ILD和肾危象。
  • 核点型伴抗SMN抗体者注意钙质沉着,但ILD和肾危象风险较低。

局限性

  • 回顾性设计,样本量20例。
  • 基于专家诊断,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe systemic sclerosis (SSc) with myopathy in patients without classic SSc-specific and SSc-overlap autoantibodies (aAbs), referred to as seronegative scleromyositis. METHODS: Twenty patients with seronegative scleromyositis diagnosed by expert opinion were analysed retrospectively for SSc features at myositis diagnosis and follow-up, and stratified based on HEp-2 nuclear patterns by indirect immunofluorescence (IIF) according to International Consensus of Autoantibody Patterns. Specificities were analysed by protein A-assisted immunoprecipitation. Myopathy was considered an organ involvement of SSc. RESULTS: SSc sine scleroderma was a frequent presentation (45%) at myositis diagnosis. Myositis was the most common first non-Raynaud manifestation of SSc (55%). Lower oesophagal dysmotility was present in 10 of 11 (91%) investigated patients. At follow-up, 80% of the patients met the American College of Rheumatology/EULAR SSc classification criteria. Two-thirds of patients had a positive HEp-2 IIF nuclear pattern (all with titers ≥1/320), defining three novel scleromyositis subsets. First, antinuclear antibody (ANA)-negative scleromyositis was associated with interstitial lung disease (ILD) and renal crisis. Second, a speckled pattern uncovered multiple rare SSc-specific aAbs. Third, the nuclear dots pattern was associated with aAbs to survival of motor neuron (SMN) complex and a novel scleromyositis subset characteriszed by calcinosis but infrequent ILD and renal crisis. CONCLUSIONS: SSc skin involvement is often absent in early seronegative scleromyositis. ANA positivity, Raynaud phenomenon, SSc-type capillaroscopy and/or lower oesophagal dysmotility may be clues for scleromyositis. Using HEp-2 IIF patterns, three novel clinicoserological subsets of scleromyositis emerged, notably (1) ANA-negative, (2) ANA-positive with a speckled pattern and (3) ANA-positive with nuclear dots and anti-SMN aAbs.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Landon-Cardinal O, Baril-Dionne A, Hoa S, et al. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. RMD Open. 2020. PMID: 32892170. doi:10.1136/rmdopen-2020-001357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。